Heron Therapeutics, Inc. (0J4V.L)
USD 1.62
(0.31%)
USD 1.62
(0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -58.78 Million | -146.91 Million | -203.35 Million | -184.82 Million | -124.58 Million | -191.8 Million |
| Net Income | -110.55 Million | -182.02 Million | -220.68 Million | -227.27 Million | -204.74 Million | -178.84 Million |
| Depreciation & Amortization | 3.23 Million | 2.88 Million | 3.02 Million | 2.84 Million | 2.04 Million | 1.51 Million |
| Deferred income taxes | -34.26 Million | -20.23 Million | -46.72 Million | -31.31 Million | -90.24 Million | 18.53 Million |
| Stock-based compensation | 32.85 Million | 42.98 Million | 46.85 Million | 50.21 Million | 51.41 Million | 33.36 Million |
| Change in working capital | 16.77 Million | -10.5 Million | -35.07 Million | -13 Million | 29.23 Million | -45.42 Million |
| Other non-cash items | -1.09 Million | 71.82 Million | 52.27 Million | 79.45 Million | 28.24 Million | 87.77 Million |
| Investing Cash Flow | 17.99 Million | -3.32 Million | 32.72 Million | 208.95 Million | -21.78 Million | -278.55 Million |
| Investments in PPE | -1.54 Million | -1.82 Million | -3.02 Million | -6.81 Million | -7.15 Million | -9.17 Million |
| Acquisitions | 13 Thousand | 227 Thousand | 32 Thousand | -215.76 Million | 14.62 Million | 25 Thousand |
| Investment purchases | -87.65 Million | -145.68 Million | -129.22 Million | -134 Million | -477.03 Million | -497.1 Million |
| Sales/Maturities of investments | 107.18 Million | 143.95 Million | 164.94 Million | 349.77 Million | 462.4 Million | 227.7 Million |
| Other Investing Activities | 19.54 Million | -1.49 Million | 35.75 Million | 215.76 Million | -14.62 Million | -269.37 Million |
| Financing Cash Flow | 54.1 Million | 75.05 Million | 156.02 Million | 9.1 Million | 186.42 Million | 357.6 Million |
| Debt repayment | -24.35 Million | - | -148.96 Million | -26 Thousand | - | -25 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 29.75 Million | 75.05 Million | 7.06 Million | 9.07 Million | 186.42 Million | 382.6 Million |
| Other Financing Activities | 29.75 Million | 75.05 Million | 7.06 Million | 9.1 Million | 186.42 Million | 357.6 Million |
| Accounts receivables | -8.08 Million | -16.55 Million | 6.35 Million | -1.97 Million | 24.77 Million | -22.77 Million |
| Accounts payables | 15 Thousand | -578 Thousand | 3.27 Million | -2.23 Million | -14.1 Million | -1.9 Million |
| Inventory | 12.46 Million | -6.19 Million | -6.47 Million | -16.93 Million | 14.06 Million | -29.12 Million |
| Other working capital | 12.4 Million | 12.81 Million | -38.23 Million | 8.13 Million | 4.5 Million | 8.38 Million |
| Cash at beginning of period | 15.36 Million | 90.54 Million | 105.13 Million | 71.89 Million | 31.83 Million | 144.58 Million |
| Cash at end of period | 28.67 Million | 15.36 Million | 90.54 Million | 105.13 Million | 71.89 Million | 31.83 Million |
| Capital Expenditure | -1.54 Million | -1.82 Million | -3.02 Million | -6.81 Million | -7.15 Million | -9.17 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 13.31 Million | -75.17 Million | -14.59 Million | 33.24 Million | 40.06 Million | -112.74 Million |
| Free Cash Flow | -60.33 Million | -148.73 Million | -206.37 Million | -191.63 Million | -131.73 Million | -200.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.23 Million | -3.16 Million | -10.72 Million | -110.55 Million | -25 Million | -42.05 Million |
| Depreciation & Amortization | 785 Thousand | 689 Thousand | 715 Thousand | 2.89 Million | 727 Thousand | 739 Thousand |
| Deferred income taxes | - | - | -819 Thousand | -34.26 Million | -22.19 Million | 3.9 Million |
| Stock-based compensation | 4.57 Million | 3.37 Million | 4.32 Million | 32.85 Million | 6.68 Million | 13.9 Million |
| Change in working capital | -12.81 Million | -10.09 Million | 8.4 Million | 16.79 Million | 8.53 Million | 386 Thousand |
| Other non-cash items | 12.08 Million | 12.37 Million | 557 Thousand | 33.48 Million | -7.39 Million | 35.16 Million |
| Investing Cash Flow | 2.04 Million | 1.27 Million | -8.83 Million | 17.99 Million | -23.22 Million | 13.21 Million |
| Investments in PPE | -637 Thousand | - | -250 Thousand | -1.54 Million | -793 Thousand | -278 Thousand |
| Acquisitions | - | - | 13 Thousand | 13 Thousand | 22.42 Million | -13.49 Million |
| Investment purchases | -27.2 Million | -37.89 Million | -23.34 Million | -87.65 Million | -35.92 Million | -14.43 Million |
| Sales/Maturities of investments | 29.89 Million | 39.17 Million | 14.75 Million | 107.18 Million | 13.5 Million | 27.93 Million |
| Other Investing Activities | 2.68 Million | 1.27 Million | -8.58 Million | 19.54 Million | -22.42 Million | 13.49 Million |
| Financing Cash Flow | 492 Thousand | 11 Thousand | 199 Thousand | 54.1 Million | 53.79 Million | 319 Thousand |
| Debt repayment | - | - | -29.75 Million | -24.35 Million | -54.1 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 492 Thousand | 11 Thousand | 29.95 Million | 29.75 Million | -308 Thousand | 319 Thousand |
| Other Financing Activities | 492 Thousand | 11 Thousand | 199 Thousand | 29.75 Million | 53.79 Million | 319 Thousand |
| Accounts receivables | -8.38 Million | -5.18 Million | 3.65 Million | -8.08 Million | 12.89 Million | -25.24 Million |
| Accounts payables | 9.38 Million | -2.4 Million | 1.38 Million | 15 Thousand | -97 Thousand | -2.1 Million |
| Inventory | -391 Thousand | -363 Thousand | -103 Thousand | 12.46 Million | 2.61 Million | 7.43 Million |
| Other working capital | -4.03 Million | -2.14 Million | 3.46 Million | 12.4 Million | -6.88 Million | 20.3 Million |
| Cash at beginning of period | 20.45 Million | 28.67 Million | 34.85 Million | 15.36 Million | 13.46 Million | 27.09 Million |
| Cash at end of period | 18.38 Million | 20.45 Million | 28.67 Million | 28.67 Million | 34.85 Million | 13.46 Million |
| Capital Expenditure | -637 Thousand | - | -250 Thousand | -1.54 Million | -793 Thousand | -278 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.06 Million | -8.22 Million | -6.18 Million | 13.31 Million | 21.39 Million | -13.62 Million |
| Free Cash Flow | -5.24 Million | -9.51 Million | 2.2 Million | -60.33 Million | -9.97 Million | -27.44 Million |
5126
IRWD
024070
VBNK
NAVIGANT
KDSI